Taken together, these studies confirm the pivotal role of lncRNA UCA1 in anti-cancer drug resistance to cisplatin, gemcitabine, 5-FU, tamoxifen, imatinib and EGFR-TKIs. This evidence concerns the gene UCA1 and cancer.